Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification

被引:1
作者
Bae, Bong Kyung [1 ]
Cho, Won Kyung [1 ]
Kim, Byoung-Gie [2 ]
Choi, Chel Hun [2 ]
Kim, Tae-Joong [2 ]
Lee, Yoo-Young [2 ]
Lee, Jeong-Won [2 ]
Park, Won [1 ]
机构
[1] Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[2] Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
关键词
Adenocarcinoma; Pathology; PELVIC RADIATION-THERAPY; RADICAL HYSTERECTOMY; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; ADJUVANT THERAPY; UTERINE CERVIX; CARCINOMA; CANCER; CLASSIFICATION; INVASION;
D O I
10.1136/ijgc-2022-003971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveCervical adenocarcinoma has poorer outcomes compared with squamous cell carcinoma; however, treatment is identical irrespective of histologic sub-types. This study aimed to investigate the patterns and risk factors of recurrence following surgery alone for low-risk early-stage cervical adenocarcinoma. MethodsWe retrospectively reviewed patients who underwent surgery alone for low-risk early-stage cervical adenocarcinoma between January 2001 and December 2018 in a single institution. Baseline clinicopathological characteristics were collected to identify the factors associated with recurrence-free survival. ResultsA total of 252 patients met the inclusion criteria. Most patients underwent radical hysterectomy (218 patients, 86.5%) and had usual type endocervical adenocarcinoma (190 patients, 75.4%). The International Federation of Gynecology and Obstetrics 2018 stage was IA1 in 72 patients (27.4%), IA2 in 58 (22.1%), IB1 in 51 (19.4%), and IB2 in 71 patients (27.0%). With a median follow-up of 70.4 months (range 6.2-252.5 months), 5-year survival rates were as follows: locoregional recurrence-free survival, 93.0%; recurrence-free survival, 89.6%; overall survival, 94.7%. The recurrence patterns were local in nine patients (32.1%), regional in five patients (17.8%), distant in 10 patients (35.7%), local and distant in one patient (3.6%), regional and distant in two patients (7.2%), and locoregional and distant in one patient (3.6%). In multivariable analysis, negative human papillomavirus (HPV) status (HR 7.314; p<0.001) and deep cervical stromal invasion (HR 5.110; p=0.003) were associated with poor locoregional recurrence-free survival. Patients were stratified based on the number of risk factors and a statistically significant difference in locoregional recurrence-free survival was observed: 5-year survival rates of 99.0%, 84.2%, and 50.0% for patients with 0, 1, and 2 risk factors (0 vs 1, p=0.001; 1 vs 2, p=0.011). ConclusionSurgery alone for low-risk early-stage cervical adenocarcinoma was associated with favorable outcomes over a long follow-up period. Patients with the highest risk of recurrence were those with a negative HPV status and deep cervical stromal invasion. Additional management following surgery may be considered in patients with these risk factors.
引用
收藏
页码:1524 / 1530
页数:7
相关论文
共 50 条
  • [21] Tumor Necrotic Debris and High Nuclear Grade Newly Identified High-risk Factors for Early-stage Endocervical Adenocarcinoma
    Holloway, Steven B.
    Colon, Glorimar R.
    Zheng, Wenxin
    Lea, Jayanthi S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (04): : 162 - 168
  • [22] Analysis of the prognostic factors determining the oncological outcomes in patients with high-risk early-stage cervical cancer
    Kilic, Fatih
    Cakir, Caner
    Yuksel, Dilek
    Korkmaz, Vakkas
    Kimyon Comert, Gunsu
    Boran, Nurettin
    Koc, Sevgi
    Turan, Taner
    Turkmen, Osman
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (02) : 281 - 288
  • [23] Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors
    Yu, Hao
    Zhang, Linlin
    Du, Xuelian
    Sheng, Xiugui
    ONCOTARGETS AND THERAPY, 2016, 9 : 7331 - 7335
  • [24] Clinical outcomes and recurrence patterns of high-intermediate-risk and high-risk early-stage endometrial cancer treated with postoperative intracavitary brachytherapy
    Yan, Zihan
    Ren, Kang
    Wang, Wenhui
    Hu, Ke
    Hou, Xiaorong
    Zhang, Fuquan
    PRECISION RADIATION ONCOLOGY, 2023, 7 (03): : 181 - 188
  • [25] Risk Factors for Parametrial Involvement in Early-Stage Cervical Cancer and Identification of Patients Suitable for Less Radical Surgery
    Jiamset, Ingporn
    Hanprasertpong, Jitti
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (7-8) : 432 - 438
  • [26] Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors
    Seki, Toshiyuki
    Tanabe, Hiroshi
    Nagata, Chie
    Suzuki, Jiro
    Suzuki, Kayo
    Takano, Hirokuni
    Isonishi, Seiji
    Ochiai, Kazuhiko
    Takakura, Satoshi
    Okamoto, Aikou
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (01) : 32 - 38
  • [27] Proteomic Analyses Identify Differentially Expressed Proteins and Pathways Between Low-Risk and High-Risk Subtypes of Early-Stage Lung Adenocarcinoma and Their Prognostic Impacts
    Zhou, Juntuo
    Liu, Bing
    Li, Zhongwu
    Li, Yang
    Chen, Xi
    Ma, Yuanyuan
    Yan, Shi
    Yang, Xin
    Zhong, Lijun
    Wu, Nan
    MOLECULAR & CELLULAR PROTEOMICS, 2021, 20
  • [28] Clinicopathological Risk Factors for Pelvic Lymph Node Metastasis in Clinical Early-Stage Endometrioid Endometrial Adenocarcinoma
    Zhang, Chuyao
    Wang, Chao
    Feng, Weiwei
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (08) : 1373 - 1377
  • [29] Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer
    K Matsuo
    S Mabuchi
    M Okazawa
    Y Matsumoto
    T Tsutsui
    M Fujita
    S Kamiura
    K Ogawa
    C P Morrow
    T Kimura
    British Journal of Cancer, 2013, 108 : 1348 - 1357
  • [30] Further stratification of risk groups in patients with lymph node metastasis after radical hysterectomy for early-stage cervical cancer
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    GYNECOLOGIC ONCOLOGY, 2010, 117 (01) : 53 - 58